Company: BIVIW
Filing Date: 2025-07-03
Form Type: S-1
Source: 0001520138-25-000198
Chunk: 52

Company: BIOVIE INC.
Filing Date: 2025-07-03
Form: S-1
Chunk 52
---
, including as part of any grant funding from a third
party, or (b) any offer or sale of equity securities by the Company directly to non-U.S. persons domiciled in the following jurisdictions:
China, Korea, Latin America excluding Caribbean and the Cayman Islands) and Middle East, in each case, in a private placement not otherwise
involving a public offering. The Representative may elect, in its sole and absolute discretion, not to exercise its Right of First Refusal
with respect to any Future Transaction; provided that any such election by the Representative shall not adversely affect the Representative's
Right of First Refusal with respect to any other Future Transaction during the twelve (12) month period agreed to above.

<div align='center'>32</div>

Discretionary Accounts

The underwriters do not intend to confirm sales
of the Units and/or Pre-funded Units offered hereby to any accounts over which they have discretionary authority.

Electronic Distribution

This prospectus in electronic format may be made
available on websites or through other online services maintained by one or more of the underwriters, or by their affiliates. Other than
this prospectus in electronic format, the information on any underwriter’s website and any information contained in any other website
maintained by an underwriter is not part of this prospectus, has not been approved and/or endorsed by us or any underwriter in its capacity
as underwriter, and should not be relied upon by investors.

Nasdaq Capital Market Listing

Our Common Stock is listed on Nasdaq under the
symbol “BIVI”. We intend to apply to list the Warrants on Nasdaq under the symbol “BIVIW”. We cannot guarantee
that the Warrants will be approved for listing on Nasdaq. We do not intend to list the Pre-funded Warrants on any securities exchange
or nationally recognized trading system and do not expect a trading market to develop for the Pre-funded Warrants.

Stabilization

In connection with this offering, the underwriters
may engage in stabilizing transactions, over-allotment transactions, syndicate-covering transactions, penalty bids, and purchases to cover
positions created by short sales.

| ● | Stabilizing transactions permit bids to purchase securities so long as the stabilizing bids do not exceed a specified maximum and are engaged in for the purpose of preventing or retarding a decline in the market price of the securities while the offering is in progress.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| ● | Over-allotment transactions involve